Geron reported $-0.05 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 -0.02 -0.03 May/11
FY2025Q4 Dec/2025 -0.05 -0.03 -0.04 Feb/25
FY2025Q3 Sep/2025 -0.03 -0.03 -0.04 Nov/05
FY2025Q2 Jun/2025 -0.02 -0.03 -0.10 Aug/06
FY2025Q1 Mar/2025 -0.03 -0.03 -0.09 May/07




Eps Change Date
Amgen USD 5.29 0.35 Dec/2025
Bio Techne USD 0.46 0.04 Dec/2025
Cassava Sciences USD -0.26 0.04 Dec/2025
Cytokinetics USD -1.5 1.05 Dec/2025
Esperion Therapeutics USD 0.26 0.42 Dec/2025
Exelixis USD 0.97 0.19 Dec/2025
Genmab DKK 3.69 2.77 Dec/2025
Geron USD -0.05 0.02 Dec/2025
Gilead Sciences USD 1.86 0.61 Dec/2025
Incyte USD 1.8 0.46 Dec/2025
MacroGenics USD -0.22 0.49 Dec/2025
Novartis USD 1.54 0.5 Dec/2025
Novavax USD 0.13 0.59 Dec/2025